Stocks opened higher Thursday on strength in several chip stocks, which were boosted by assurances that President Donald Trump's proposed tariff on semiconductor imports would not apply to companies building in the U.S.
However, sentiment quickly shifted as market participants mulled over the latest round of earnings reports.
Late Wednesday, during a meeting in the Oval Office with Apple (AAPL, +3.2%) CEO Tim Cook – where the iPhone maker announced a new $100 billion investment in U.S. manufacturing over the next four years – Trump said he will impose a 100% tariff on chips being imported into the U.S.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"But the good news for companies like Apple is if you're building in the United States or have committed to build, without question, committed to build in the United States, there will be no charge," he added.
Semiconductor stocks including Nvidia (NVDA, +0.8%), Broadcom (AVGO, +0.7%) and Texas Instruments (TXN, 0.0%) jumped out of the gate Thursday in reaction, but finished the day well off their intraday highs.
Intel stock drops after Trump calls for CEO to resign
Trump also chimed in on Intel (INTC, -3.1%), though what he had to say did the embattled chipmaker no favors.
In a post on Truth Social, the president accused Intel CEO Lip-Bu Tan – who took the reins in March – of being "highly CONFLICTED" because of his alleged ties to China, and said he "must resign, immediately."
This follows a letter that Senator Tom Cotton (R-Ark.) sent to Intel's board chair, Frank Yeary, earlier this month to "express concern" over "the security and integrity of Intel's operations."
The CEO, according to Cotton, "reportedly controls dozens of Chinese companies and has a stake in hundreds of Chinese advanced-manufacturing and chip firms," including some he says that "have ties to the Chinese People's Liberation Army."
Eli Lilly sinks on disappointing weight-loss drug data
Eli Lilly (LLY) also finished in negative territory Thursday, sinking 14.1%. The pharmaceutical giant said the highest dosage of its oral obesity drug, orforglipron, helped patients lose 12% of their body weight in a late-stage trial – less than the 15% some Wall Street analysts expected.
Separately, the company reported higher-than-expected second-quarter results thanks to strong sales of its diabetes treatment Mounjaro and its weight-loss drug Zepbound. It also raised its full-year earnings and revenue outlooks.
Fortinet plunges 22% after earnings
Elsewhere on the earnings calendar, Fortinet (FTNT) stock sank 22.0% after the cybersecurity firm disclosed its second-quarter results.
While the company reported higher-than-anticipated earnings on in-line revenue, its third-quarter revenue outlook of $1.7 billion at the midpoint falls short of what Wall Street is expecting.
Additionally, many analysts were disappointed that Fortinet said its firewall refresh – where customers upgrade their existing product to a new version – is nearly halfway through.
"We have been Overweight (Buy) on Fortinet with the thesis that a large firewall refresh was coming," says Morgan Stanley analyst Keith Weiss. "Given that firewall refresh is now 40-50% complete, the catalyst we had been expecting is no longer present, causing us to downgrade the stock [to Equal Weight, the equivalent of Hold]."
Wall Street is mostly on the sidelines when it comes to the cybersecurity stock. Of the 44 analysts covering FTNT who are tracked by S&P Global Market Intelligence, seven say it's a Strong Buy, three have it at Buy, 32 say it's a Hold and two have it at Strong Sell.
Morgan Stanley downgrades Caterpillar to Sell
Morgan Stanley also chimed in on Caterpillar (CAT) after the construction giant reported lower-than-expected second-quarter earnings earlier this week.
Analyst Angel Castillo lowered his outlook on the Dow Jones stock to Underweight (the equivalent of Sell) from Equal Weight, saying shares are "priced to perfection."
The stock up more than 50% from their early April lows. "All the while," Castillo notes, "profitability and fundamentals (i.e. price/margins) have deteriorated further pointing to negative earnings revision risk."
And this skews risk to the downside for the blue chip stock, he adds. CAT finished the day down 2.5%.
As for the main indexes, the tech-heavy Nasdaq Composite rose 0.4% to 21,242, the broader S&P 500 gave back 0.08% to 6,340, and the blue-chip Dow Jones Industrial Average fell 0.5% to 43,968.
Related content
- Kiplinger's Economic Calendar: This Week's Reports and Results
- How Big Will the Fed Rate Cut Be This Fall?
- Best Tech ETFs to Buy Now
-
The Most Popular Apps for Retirement Planning in 2025A J.D. Power survey ranks retirement planning apps based on customer service and satisfaction. Does your financial app make the cut?
-
Don't Disinherit Your Grandchildren: The Hidden Risks of Retirement Account Beneficiary FormsStandard retirement account beneficiary forms may not be flexible enough to ensure your money passes to family members according to your wishes. Naming a trust as the contingent beneficiary can help avoid these issues. Here's how.
-
Don't Disinherit Your Grandchildren: The Hidden Risks of Retirement Account Beneficiary Forms
Standard retirement account beneficiary forms may not be flexible enough to ensure your money passes to family members according to your wishes. Naming a trust as the contingent beneficiary can help avoid these issues. Here's how.
-
This Is How Life Insurance Can Fund Your Dreams NowBeyond a death benefit, life insurance can provide significant financial value and flexibility through 'living benefits' while you are still alive, helping with expenses like education, business ventures or retirement.
-
Potential Trouble for Retirees: A Wealth Adviser's Guide to the OBBB's Impact on RetirementWhile some provisions might help, others could push you into a higher tax bracket and raise your costs. Be strategic about Roth conversions, charitable donations, estate tax plans and health care expenditures.
-
One Small Step for Your Money, One Giant Leap for RetirementSaving enough for retirement can sound as daunting as walking on the moon. But what would your future look like if you took one small step toward it this year?
-
This Is What You Really Need to Know About Medicare, From a Financial ExpertHealth care costs are a significant retirement expense, and Medicare offers essential but complex coverage that requires careful planning. Here's how to navigate Medicare's various parts, enrollment periods and income-based costs.
-
I'm a Financial Planner: Could Partial Retirement Be the Right Move for You?Many Americans close to retirement are questioning whether they should take the full leap into retirement or continue to work part-time.
-
From Mortgages to Taxes to Estates: How to Prepare for Falling Interest RatesAs speculation grows that the Federal Reserve will soon start lowering interest rates, now is a good time to review your financial plans for housing, estate, taxes, investing and retirement to make the most of potential changes.
-
This Is How Lottery Winners Build Lasting Legacies, From a Financial ProfessionalWinning a massive lottery jackpot, like the recent $1.4 billion Powerball, requires seeking immediate legal and financial counsel, protecting your identity and winnings and planning your legacy.
